Centene Corporation vs Molina Healthcare, Inc.: Strategic Comparison

This in-depth comparison examines Centene Corporation and Molina Healthcare, Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Centene Corporation on its own, evaluating Molina Healthcare, Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Centene Corporation and Molina Healthcare, Inc. is widest.

On the headline numbers, Centene Corporation reports annual revenue of $194.8B against $45.4B for Molina Healthcare, Inc., while their respective market capitalizations stand at $30.5B and $9.9B. Centene Corporation is headquartered in United States and Molina Healthcare, Inc. operates from United States, and those different home markets shape how each company competes.

Centene Corporation: Centene is a Fortune 500 healthcare company that runs a large share of America's government-funded health coverage. Unlike insurers built on employer plans, it focuses on Medicaid, the ACA Marketplace through its Ambetter brand, and Medicare through Wellcare. Headquartered in St. Louis, Missouri, it is the largest Medicaid managed care organization in the U.S., serving about 12.1 million Medicaid members, 3.5 million Marketplace members and 8.8 million Medicare Part D members as of June 30, 2026.

Molina Healthcare, Inc.: Molina Healthcare is a Fortune 500 managed care company based in Long Beach, California, that serves people covered by government programs: Medicaid, Medicare and ACA Marketplace plans. It does not compete for large employer accounts the way UnitedHealthcare or Elevance Health do. At December 31, 2025 it served about 5.5M members in 21 states and employed about 19,000 people; by June 30, 2026 membership had fallen to about 4.93M as Medicaid attrition and Marketplace cuts took effect.

Centene Corporation and Molina Healthcare, Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Centene Corporation and Molina Healthcare, Inc..

Centene Corporation business model: Centene earns most of its money from premiums paid by governments. State Medicaid agencies pay it a fixed monthly amount per enrolled member to manage that member's care; the federal Centers for Medicare & Medicaid Services (CMS) pays it for Medicare Advantage and Part D drug plans; and ACA Marketplace members pay Ambetter premiums that are largely funded by federal tax credits. Centene then contracts with doctors, hospitals and pharmacies and profits only if total medical costs plus administrative expenses come in below those premiums. That spread is thin: in Q2 2026 its health benefits ratio was 89.6% and its SG&A ratio 7.0%, so small swings in medical use or rates move earnings sharply.

Molina Healthcare, Inc. business model: Molina is a government-program health insurer. States and the federal Centers for Medicare & Medicaid Services pay it a fixed monthly premium per enrolled member (capitation), and Molina pays doctors, hospitals and pharmacies for those members' care. Profit is the gap between premiums and the medical cost ratio (MCR) plus administrative expense. In 2025 premium revenue was $43.1B of $45.4B total revenue, and Medicaid was the largest segment, followed by Medicare (mostly dual-eligible members) and Marketplace. Because rates are set by states and CMS, Molina's earnings depend on whether rate updates keep pace with medical cost trend.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Centene Corporation stack up against those of Molina Healthcare, Inc..

Centene Corporation competitive advantage: Centene's main advantage is scale and experience in state Medicaid programs. It serves about 12.1 million Medicaid members across 30 states, and every state runs its own procurement, rate-setting and compliance rules. Winning and keeping those contracts requires local provider networks, quality reporting and regulatory relationships built over decades, which makes it hard for new entrants to compete for large state awards.

Molina Healthcare, Inc. competitive advantage: Molina's edge is focus. It does not sell employer coverage, so its bidding, care management and cost structure are built around Medicaid and dual-eligible members. It runs one of the lowest administrative cost ratios among large insurers (an adjusted G&A ratio of 6.5% in 2025) and has a record of winning state procurements, including the Florida Children's Medical Services contract and new awards in Georgia and Texas due to start in 2027. That focus also means it has less diversification when government rates lag costs.

Future prospects matter as much as current results. The growth strategies below explain how Centene Corporation and Molina Healthcare, Inc. each plan to expand from here.

Centene Corporation growth strategy: Under CEO Sarah London, who succeeded Michael Neidorff in 2022, Centene has narrowed its focus to U.S. government-sponsored health plans. It sold non-core assets such as Magellan Rx, its Spanish hospital operator Ribera Salud and UK-based Circle Health, outsourced pharmacy benefit management to Express Scripts, and cut administrative costs. Growth now centers on repricing Marketplace plans for profitability, expanding Medicare Part D (8.8 million PDP members at June 30, 2026), dual-eligible Medicaid-Medicare plans, and improving Medicare Advantage Star Ratings.

Molina Healthcare, Inc. growth strategy: Molina grows through state Medicaid procurements and bolt-on acquisitions of regional health plans. Recent deals include Magellan Complete Care (closed December 31, 2020), Affinity Health Plan in New York (2021), My Choice Wisconsin (2022), Bright Health's California Medicare business (2024) and ConnectiCare in Connecticut ($350M, closed February 1, 2025). In Medicare it is narrowing to dual-eligible products (D-SNP, HIDE and FIDE plans), where Medicaid and Medicare benefits are coordinated in one plan.

A closer look at the financial trajectory of Centene Corporation and Molina Healthcare, Inc. rounds out the comparison.

Centene Corporation: Centene's revenue grew from $144.5 billion in 2022 to $194.8 billion in 2025, but profit moved the other way. FY2025 ended with a $6.674 billion GAAP net loss attributable to Centene, compared with $3.3 billion of net income in 2024, after a $6.7 billion non-cash goodwill impairment recorded in Q3 2025; adjusted diluted EPS was $2.08. The turnaround showed up in 2026: Q2 2026 total revenue was $53.6 billion, premium and service revenue was $44.4 billion, GAAP diluted EPS was $2.19 and adjusted diluted EPS was $2.51. Centene raised its 2026 guidance to GAAP diluted EPS above $3.11 and adjusted diluted EPS above $4.80, with premium and service revenue guided to $173-$177 billion. The company does not pay a dividend.

Molina Healthcare, Inc.: Revenue rose from $19.4B in 2020 to $45.4B in 2025, driven by acquisitions and new state contracts, but profit moved the other way in 2025. Net income fell to $472M from $1.18B in 2024, and adjusted EPS of $11.03 was less than half the initial $24.50 guidance, after elevated Medicare and Marketplace costs and two retroactive California Medicaid items. For 2026 Molina guided to about $42B of premium revenue and, after Q2 2026, adjusted EPS of at least $5.25. Q2 2026 premium revenue was $10.2B, down 6% year over year, with a consolidated MCR of 92.2%.